Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Awareness of SARS-CoV-2 Omicron Variant Infection Among Adults With Recent COVID-19 Seropositivity
Sandy Joung, Joseph E. Ebinger, Nancy Sun, et al.
JAMA Network Open (2022) Vol. 5, Iss. 8, pp. e2227241-e2227241
Open Access | Times Cited: 44

Showing 1-25 of 44 citing articles:

The omicron variant of SARS-CoV-2 drove broadly increased seroprevalence in a public university setting
Ching‐Wen Hou, Stacy Williams, Guillermo Trivino-Soto, et al.
PLOS Global Public Health (2025) Vol. 5, Iss. 1, pp. e0003893-e0003893
Open Access | Times Cited: 1
Serial cross-sectional estimation of vaccine-and infection-induced SARS-CoV-2 seroprevalence in British Columbia, Canada
Danuta M. Skowronski, Samantha E Kaweski, Michael A. Irvine, et al.
Canadian Medical Association Journal (2022) Vol. 194, Iss. 47, pp. E1599-E1609
Open Access | Times Cited: 45
Chronic Pulmonary Manifestations of COVID-19 Infection: Imaging Evaluation
Mark C. Murphy, Brent P. Little
Radiology (2023) Vol. 307, Iss. 2
Open Access | Times Cited: 21
Opportunities and Challenges in Using Electronic Health Record Systems to Study Postacute Sequelae of SARS-CoV-2 Infection: Insights From the NIH RECOVER Initiative
Hannah Mandel, Shruti Shah, L. Charles Bailey, et al.
Journal of Medical Internet Research (2025) Vol. 27, pp. e59217-e59217
Open Access
Estimating SARS‐CoV‐2 infections and associated changes in COVID‐19 severity and fatality
Valentina Marziano, Giorgio Guzzetta, Francesco Menegale, et al.
Influenza and Other Respiratory Viruses (2023) Vol. 17, Iss. 8
Open Access | Times Cited: 14
SARS-CoV-2 infection- induced seroprevalence among children and associated risk factors during the pre- and omicron-dominant wave, from January 2021 through December 2022, Thailand: A longitudinal study
Nungruthai Suntronwong, Preeyaporn Vichaiwattana, Sirapa Klinfueng, et al.
PLoS ONE (2023) Vol. 18, Iss. 4, pp. e0279147-e0279147
Open Access | Times Cited: 12
Concurrent Administration of COVID-19 and Influenza Vaccines Enhances Spike-Specific Antibody Responses
Susanna E Barouch, Taras M. Chicz, Ross Blanc, et al.
Open Forum Infectious Diseases (2024) Vol. 11, Iss. 4
Open Access | Times Cited: 3
Cumulative and undiagnosed SARS-CoV-2 infection among the staff of a medical research centre in Tokyo after the emergence of variants
Tetsuya Mizoue, Shohei Yamamoto, Yusuke Oshiro, et al.
Epidemiology and Infection (2023) Vol. 151
Open Access | Times Cited: 9
Selective adaptation of SARS-CoV-2 Omicron under booster vaccine pressure: a multicentre observational study
Ralf Duerr, Dacia Dimartino, Christian Marier, et al.
EBioMedicine (2023) Vol. 97, pp. 104843-104843
Open Access | Times Cited: 9
COVID-19 in Japan during 2020-2022: Characteristics, responses, and implications for the health care system
Kenji Karako, Peipei Song, Yuyan Chen, et al.
Journal of Global Health (2022) Vol. 12
Open Access | Times Cited: 14
Association of SARS-CoV-2 Nucleocapsid Protein Mutations with Patient Demographic and Clinical Characteristics during the Delta and Omicron Waves
Feda A. Alsuwairi, Asma N. Alsaleh, Madain S. Alsanea, et al.
Microorganisms (2023) Vol. 11, Iss. 5, pp. 1288-1288
Open Access | Times Cited: 8
The evolving epidemiology of SARS-CoV-2
Catherine Bennett, Hassan Vally
Microbiology Australia (2024), pp. NULL-NULL
Open Access | Times Cited: 2
Trends in Risk Factors and Symptoms Associated With SARS-CoV-2 and Rhinovirus Test Positivity in King County, Washington, June 2020 to July 2022
C. Hansen, Amanda C. Perofsky, Roy Burstein, et al.
JAMA Network Open (2022) Vol. 5, Iss. 12, pp. e2245861-e2245861
Open Access | Times Cited: 12
Increased SARS-CoV-2 seroprevalence and spread of infection without awareness among healthcare workers through 2020–2022 in a Japanese medical center
Rie Kanamori, Yan Yan, Kanami Ito, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 6
Long‐term durability of antibody responses after SARS‐CoV‐2 vaccination and influencing factors
Joseph E. Ebinger, Sandy Joung, Minhao Wang, et al.
Journal of Internal Medicine (2023) Vol. 293, Iss. 4, pp. 520-523
Closed Access | Times Cited: 5
Perceived Hospital Stress, Severe Acute Respiratory Syndrome Coronavirus 2 Activity, and Care Process Temporal Variance During the COVID-19 Pandemic*
George L. Anesi, Adair Andrews, He Bai, et al.
Critical Care Medicine (2023) Vol. 51, Iss. 4, pp. 445-459
Open Access | Times Cited: 5
Assessing the post hoc effectiveness of tixagevimab−cilgavimab for prevention of SARS‐CoV‐2 infections in solid organ transplant recipients
Stanley C. Jordan, Sandy Joung, Minhao Wang, et al.
Transplant Infectious Disease (2023) Vol. 26, Iss. 1
Open Access | Times Cited: 5
Suppression of the alpha, delta, and omicron variants of SARS-Cov-2 in Taiwan
Hsiao‐Hui Tsou, Fang-Jing Lee, Shiow‐Ing Wu, et al.
PLoS ONE (2024) Vol. 19, Iss. 3, pp. e0300303-e0300303
Open Access | Times Cited: 1
Screening Strategies to Reduce COVID-19 Mortality in Nursing Homes
Shirley Dong, Eric Jutkowitz, John Giardina, et al.
JAMA Health Forum (2024) Vol. 5, Iss. 4, pp. e240688-e240688
Open Access | Times Cited: 1
Association of SARS-CoV-2 Nucleocapsid Protein Mutations with Patient Demographic and Clinical Characteristics during the Delta and Omicron Waves
Feda A. Alsuwairi, Asma N. Alsaleh, Madain S. Alsanea, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 4
Serial SARS-CoV-2 Antibody Titers in Vaccinated Dialysis Patients: Prevalence of Unrecognized Infection and Duration of Seroresponse
Caroline M. Hsu, Daniel E. Weiner, Harold J. Manley, et al.
Kidney Medicine (2023) Vol. 5, Iss. 11, pp. 100718-100718
Open Access | Times Cited: 4
Serial cross-sectional estimation of vaccine and infection-induced SARS-CoV-2 sero-prevalence in children and adults, British Columbia, Canada: March 2020 to August 2022
Danuta M. Skowronski, Samantha E Kaweski, Michael A. Irvine, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 6
Prevalence and Outcomes of COVID-19 among Hematology/Oncology Patients and Providers of a Community-Facing Health System during the B1.1.529 (“Omicron”) SARS-CoV-2 Variant Wave
Samuel A. Kareff, Aliya Khan, Priscila Barreto‐Coelho, et al.
Cancers (2022) Vol. 14, Iss. 19, pp. 4629-4629
Open Access | Times Cited: 6
Hits and Misses: Digital Contact Tracing in a Pandemic
Maryanne Garry, Rachel Zajac, Lorraine Hope, et al.
Perspectives on Psychological Science (2023) Vol. 19, Iss. 4, pp. 675-685
Open Access | Times Cited: 3
Diverse immune responses in vaccinated individuals with and without symptoms after omicron exposure during the recent outbreak in Guangzhou, China
Ming Gao, Xiaomin Xing, Wenbiao Hao, et al.
Heliyon (2024) Vol. 10, Iss. 2, pp. e24030-e24030
Open Access
Page 1 - Next Page

Scroll to top